For U.S. residents only. Non-U.S. residents Novartis Pharma US
Learn About Novartis
   
Learn About Clinical Trials
                                   
Non-U.S. Residents


Novartis Oncology is conducting a clinical research study to evaluate the safety and efficacy of the investigational drug SOM230 for participants 18 years of age and older who have carcinoid tumors.

Participation in this study is ongoing in many countries including:

  • Argentina
  • Austria
  • Belgium
  • Brazil
  • Canada
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Norway
  • Poland
  • Singapore
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

If you are not a US resident, please visit the ClinicalTrials.gov website for information.

 

Novartis Pharma US